Share Options—Granted share options expire at the earlier of termination of employment or ten years from the date of grant. Share options generally vest over four years of the employment commencement date or with 25% vesting on the twelve-month anniversary of the employment commencement date, and the remaining on a pro-rata basis each quarter over the next three years. Any options, which are forfeited or not exercised before expiration, become available for future grants.

The following table summarized the Company’s share option activity during the nine months ended September 30, 2024:


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (000’s)
















Balance, December 31, 2023	4,250,988	$	7.2	7.2	$	43,940
Granted	4,450	—
Exercised	(508,941)	6.1
Forfeited	(257,259)	21.2
Balance, September 30, 2024	3,489,238	$	6.4	6.4	$	20,949
Vested and exercisable, September 30, 2024	3,148,937	$	5.3	6.3	$	22,276

The aggregate intrinsic value of options exercised was approximately $3.2 million and $7.6 million for the nine months ended September 30, 2024 and 2023, respectively. The total fair value of share options vested for the nine months ended September 30, 2024 and 2023, was $58.8 million and $63.6 million, respectively.

The assumptions used to estimate the fair value of share options granted for the nine months ended September 30, 2024 September 30, 2024 were as follows:

As of September 30, 2024, unrecognized compensation expense related to unvested share options was approximately $21.4 million, which is expected to be recognized over a remaining weighted-average period of 0.8 years.

Restricted Stock Units (RSUs)—RSUs generally vest over two years of the employment commencement date with 50% vesting on the twelve-month anniversary of the employment commencement date, and the remaining on a pro-rata basis each quarter over the remaining twelve months. RSUs granted are forfeited at termination of employment. Any RSUs, which are forfeited or not exercised before expiration, become available for future grants.


	Number of RSUs	Weighted Average Grant Date Fair Value Per Share








Unvested at December 31,2023	3,034,203	$	15.6
Granted	2,803,283	10.9
Vested	(1,872,182)	13.8
Forfeited	(809,746)	15.2
Unvested at September 30, 2024	3,155,558	$	12.6

As of September 30, 2024, unrecognized compensation expense related to RSUs was approximately $32.0 million, which is expected to be recognized over a remaining weighted-average period of 1.1 years.

Options to Restricted Shares—Options to restricted shares were granted to certain employees and directors during 2021. See Note 16 to the consolidated financial statements included in the Annual Report on Form 10-K for additional information.

The following table summarized the Company’s options to restricted shares activity during the nine months ended September 30, 2024:


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (000’s)












Balance, December 31, 2023	20,046,080	$	19.4	7.2	$	—
Granted	—	—
Exercised	(14,858)	12.2
Forfeited	(60,892)	40.6
Balance, September 30, 2024	19,970,330	$	19.4	6.5	$	—
Vested and exercisable, September 30, 2024	16,541,299	$	19.3	6.5	$	—

At September 30, 2024, unrecognized compensation expense related to options to restricted shares was approximately $13.1 million, which is expected to be recognized over a remaining weighted-average period of 1.4 years.

Employee Stock Purchase Plan—The Employee Stock Purchase Plan (“ESPP”) allows eligible employees to purchase shares of our Class A Ordinary Shares at a discounted price, normally through payroll deductions, subject to the terms of the ESPP and applicable law. During the three and nine months ended September 30, 2024, 59,145 shares were issued under the ESPP. As of September 30, 2024, 0.8 million shares of Class A Ordinary Shares were reserved for issuance under the ESPP. Compensation expense related to the ESPP was $0.4 million for the nine months ended September 30, 2024.

The following table presents the components and classification of share-based compensation for the three and nine months ended September 30, 2024 and 2023 (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Technology, data and product development	$	1,011	$	3,467	$	6,985	$	8,915
Selling and marketing	2,875		3,469		9,594		10,979
General and administrative	8,447		13,801		29,273		37,418
Total	$	12,333	$	20,737	$	45,852	$	57,312